Brazil · Delayed Price · Currency is BRL Bradsaúde Statistics
Total Valuation
Bradsaúde has a market cap or net worth of BRL 40.69 billion. The enterprise value is 40.84 billion.
| Market Cap | 40.69B |
| Enterprise Value | 40.84B |
Important Dates
The last earnings date was Monday, August 3, 2026.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | Jul 1, 2026 |
Share Statistics
Bradsaúde has 2.92 billion shares outstanding.
| Current Share Class | 2.92B |
| Shares Outstanding | 2.92B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.81% |
| Float | 252.88M |
Valuation Ratios
The trailing PE ratio is 11.69 and the forward PE ratio is 8.44. Bradsaúde's PEG ratio is 1.18.
| PE Ratio | 11.69 |
| Forward PE | 8.44 |
| PS Ratio | 3.81 |
| PB Ratio | 2.18 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | 64.16 |
| P/OCF Ratio | 62.95 |
| PEG Ratio | 1.18 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.05, with an EV/FCF ratio of 64.39.
| EV / Earnings | 38.75 |
| EV / Sales | 3.82 |
| EV / EBITDA | 22.05 |
| EV / EBIT | 22.06 |
| EV / FCF | 64.39 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.07 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.32 |
| Interest Coverage | 5.03 |
Financial Efficiency
Return on equity (ROE) is 10.54% and return on invested capital (ROIC) is 7.84%.
| Return on Equity (ROE) | 10.54% |
| Return on Assets (ROA) | 5.03% |
| Return on Invested Capital (ROIC) | 7.84% |
| Return on Capital Employed (ROCE) | 6.55% |
| Weighted Average Cost of Capital (WACC) | 7.53% |
| Revenue Per Employee | 5.46M |
| Profits Per Employee | 538,577 |
| Employee Count | 1,957 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 3,419.12 |
Taxes
In the past 12 months, Bradsaúde has paid 378.35 million in taxes.
| Income Tax | 378.35M |
| Effective Tax Rate | 26.42% |
Stock Price Statistics
The stock price has increased by +7.08% in the last 52 weeks. The beta is 0.49, so Bradsaúde's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +7.08% |
| 50-Day Moving Average | 14.39 |
| 200-Day Moving Average | 13.18 |
| Relative Strength Index (RSI) | 42.63 |
| Average Volume (20 Days) | 4,598,005 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bradsaúde had revenue of BRL 10.68 billion and earned 1.05 billion in profits. Earnings per share was 1.19.
| Revenue | 10.68B |
| Gross Profit | 3.14B |
| Operating Income | 1.76B |
| Pretax Income | 1.43B |
| Net Income | 1.05B |
| EBITDA | 1.75B |
| EBIT | 1.76B |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 13.19 billion in cash and 204.83 million in debt, with a net cash position of -143.59 million or -0.05 per share.
| Cash & Cash Equivalents | 13.19B |
| Total Debt | 204.83M |
| Net Cash | -143.59M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 18.71B |
| Book Value Per Share | 6.40 |
| Working Capital | 964.17M |
Cash Flow
In the last 12 months, operating cash flow was 646.46 million and capital expenditures -12.20 million, giving a free cash flow of 634.26 million.
| Operating Cash Flow | 646.46M |
| Capital Expenditures | -12.20M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -17.62M |
| Free Cash Flow | 634.26M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 29.36%, with operating and profit margins of 16.52% and 9.87%.
| Gross Margin | 29.36% |
| Operating Margin | 16.52% |
| Pretax Margin | 13.40% |
| Profit Margin | 9.87% |
| EBITDA Margin | 16.41% |
| EBIT Margin | 16.52% |
| FCF Margin | 6.32% |
Dividends & Yields
This stock pays an annual dividend of 0.81, which amounts to a dividend yield of 5.89%.
| Dividend Per Share | 0.81 |
| Dividend Yield | 5.89% |
| Dividend Growth (YoY) | -63.66% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.20% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.89% |
| Earnings Yield | 2.59% |
| FCF Yield | 1.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Bradsaúde is 17.69, which is 27.08% higher than the current price. The consensus rating is "Buy".
| Price Target | 17.69 |
| Price Target Difference | 27.08% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 183.65% |
| EPS Growth Forecast (3Y) | 16.51% |
Stock Splits
The last stock split was on April 5, 2022. It was a forward split with a ratio of 1.1.
| Last Split Date | Apr 5, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |